Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end‐stage renal disease on maintenance haemodialysisSunil Taneja, Harbir Singh Kohli, Mini P. Singh et al.|Liver International|2020Cited by 27
FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis – Validation in an Indian CohortArka De, Ajay Duseja, Amarjit Keisham et al.|Journal of Clinical and Experimental Hepatology|2021Cited by 24
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease <scp>–</scp> The Gut and Obesity in Asia (GO‐ASIA) StudyNipun Verma, Dan Yock Young, Ajay Duseja et al.|Alimentary Pharmacology & Therapeutics|2024Cited by 23
Temporal Trends in Etiologies and Mortality of Acute Liver Failure: A 12-Year Retrospective AnalysisNipun Verma, Ajay Duseja, Muhammad Uwais Ashraf et al.|Journal of Clinical and Experimental Hepatology|2025Cited by 1